1. Home
  2. SLGL vs ELTK Comparison

SLGL vs ELTK Comparison

Compare SLGL & ELTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLGL
  • ELTK
  • Stock Information
  • Founded
  • SLGL 1997
  • ELTK 1970
  • Country
  • SLGL Israel
  • ELTK Israel
  • Employees
  • SLGL N/A
  • ELTK N/A
  • Industry
  • SLGL Biotechnology: Pharmaceutical Preparations
  • ELTK Electrical Products
  • Sector
  • SLGL Health Care
  • ELTK Technology
  • Exchange
  • SLGL Nasdaq
  • ELTK Nasdaq
  • Market Cap
  • SLGL 69.1M
  • ELTK 73.2M
  • IPO Year
  • SLGL 2018
  • ELTK 1997
  • Fundamental
  • Price
  • SLGL $39.30
  • ELTK $11.25
  • Analyst Decision
  • SLGL
  • ELTK
  • Analyst Count
  • SLGL 0
  • ELTK 0
  • Target Price
  • SLGL N/A
  • ELTK N/A
  • AVG Volume (30 Days)
  • SLGL 19.1K
  • ELTK 5.1K
  • Earning Date
  • SLGL 11-14-2025
  • ELTK 11-18-2025
  • Dividend Yield
  • SLGL N/A
  • ELTK 1.70%
  • EPS Growth
  • SLGL N/A
  • ELTK N/A
  • EPS
  • SLGL N/A
  • ELTK 0.45
  • Revenue
  • SLGL $23,931,000.00
  • ELTK $49,563,000.00
  • Revenue This Year
  • SLGL N/A
  • ELTK $18.60
  • Revenue Next Year
  • SLGL $31.17
  • ELTK $9.04
  • P/E Ratio
  • SLGL N/A
  • ELTK $25.03
  • Revenue Growth
  • SLGL 264.86
  • ELTK 6.75
  • 52 Week Low
  • SLGL $4.01
  • ELTK $7.65
  • 52 Week High
  • SLGL $52.26
  • ELTK $12.19
  • Technical
  • Relative Strength Index (RSI)
  • SLGL 67.60
  • ELTK 66.65
  • Support Level
  • SLGL $34.80
  • ELTK $10.80
  • Resistance Level
  • SLGL $52.26
  • ELTK $11.30
  • Average True Range (ATR)
  • SLGL 4.38
  • ELTK 0.16
  • MACD
  • SLGL 0.93
  • ELTK 0.06
  • Stochastic Oscillator
  • SLGL 47.70
  • ELTK 90.75

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

About ELTK Eltek Ltd.

Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. It manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnect, flex-rigid and multi-layered boards. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. Its geographic areas are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.

Share on Social Networks: